Each year, Piper Jaffray asks its analysts to provide the one name in their universe where they believe they have a differentiated opinion, high conviction and see catalysts ahead in the coming year.
Piper Jaffray’s Top Picks in healthcare for 2016 are Boston Scientific (NYSE:BSX), Cara Therapeutics (NASDAQ:CARA), Cepheid (NASDAQ:CPHD), Horizon Pharma (NASDAQ:HZNP), Ignyta (NASDAQ:RXDX), Novavax (NASDAQ:NVAX), Pfizer (NYSE:PFE), ZELTIQ Aesthetics (NASDAQ:ZLTQ) and Zoetis (NYSE:ZTS).
All of the stocks in the Top Picks list are rated “overweight.”
